Stay updated on Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, which appears to be a minor system or UI update with no changes to study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T14:33:23.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, indicating a minor update. No visible changes to user-facing content were observed.
    Difference
    0.0%
    Check dated 2026-02-07T09:00:59.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a glossary toggle and new metadata items (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0) and removed obsolete metadata (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-24T07:35:09.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.3.4 updated on the page, replacing v3.3.3; this is a minor metadata update with no changes to study information.
    Difference
    0.0%
    Check dated 2026-01-17T06:26:01.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added a Locations section listing participating sites by state (Arizona, California, Colorado, Connecticut, Florida, Illinois, Kansas, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Utah) and included a Revision: v3.3.3 tag. Removed the previous HHS Vulnerability Disclosure entry and older state location entries (v3.3.2).
    Difference
    1%
    Check dated 2025-12-19T21:36:54.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    New revision tag v3.3.2 added with recent dates (e.g., 2025-11-21 and 2025-11-24), replacing the previous revision v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-28T13:07:24.000Z thumbnail image

Stay in the know with updates to Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.